PubRank

Hervé Decousus

Author PubWeight™ 48.88‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012 11.86
2 Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010 9.92
3 Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 2004 4.52
4 Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med 2007 3.64
5 Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 2007 2.32
6 Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J 2013 2.21
7 Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 2006 2.18
8 Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention. Clin Pharmacokinet 2011 2.09
9 Extended prophylaxis of venous thromboembolism with idraparinux. N Engl J Med 2007 1.84
10 Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women: a prospective cohort of 2736 women. Thromb Res 2008 1.41
11 Clinical relevance of symptomatic superficial-vein thrombosis extension: lessons from the CALISTO study. Blood 2013 1.39
12 Compliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trial. Thromb Haemost 2003 1.29
13 Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. Thromb Haemost 2009 0.94
14 Optimal low-molecular-weight heparin regimen in major orthopaedic surgery. A meta-analysis of randomised trials. Thromb Haemost 2003 0.92
15 Intravenous thrombolytic therapy in patients with phlegmasia caerulea dolens. Haematologica 2006 0.89
16 Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis. Chest 2005 0.79
17 The risk of subsequent cancer and arterial cardiovascular events in patients with superficial vein thrombosis in the legs. Blood 2011 0.79
18 The cloud of pulmonary embolism during COPD exacerbation. Thorax 2011 0.78
19 Role of fibrinolysis and interventional therapy for acute venous thromboembolism. Thromb Haemost 2006 0.76
20 Thrombosis prophylaxis in cancer patients with a central venous catheter. Arch Intern Med 2004 0.75
21 [Initial treatment of venous thromboembolic events]. Rev Prat 2007 0.75
22 The location of deep-vein thrombosis as a predictive factor for recurrence and cancer discovery after proximal deep-vein thrombosis. Haematologica 2003 0.75
23 [New oral anticoagulants in the treatment of venous thromboembolism]. Presse Med 2013 0.75
24 Lessons learned from cancer/VTE Registries: report from RIETE. Thromb Res 2007 0.75
25 [Epidemiologic and therapeutic advances in superficial venous thrombosis of the legs]. Rev Prat 2011 0.75